9:00am - 5:00pm
Our Opening Hours Mon. - Fri.
1.800.799.2234
Call Us For Free Consultation
A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma...
Continue readingOlaparib in People With Malignant Mesothelioma...
Continue readingDENdritic Cell Immunotherapy for Mesothelioma...
Continue readingAnti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma...
Continue readingCheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma...
Continue readingMesothelioma and Radical Surgery 2...
Continue readingPembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma...
Continue readingAccelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma...
Continue readingIntrapleural Cryotherapy for Malignant Pleural Mesothelioma...
Continue readingMEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma...
Continue reading